High rates of vulnerability on a geriatric assessment were identified in a cohort of fit patients aged 60 years or older with acute myeloid leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results